Hinge Health, Inc.
Market Cap
$3.47B
P/E Ratio
-5.58
EPS
$-7.91
Dividend Yield
0.00%
52-Week Range
$30.08 — $62.18
Volume
1.17M
Avg Volume
1.26M
Beta
1.75
P/E (TTM)
-5.58
Forward P/E
23.12
PEG Ratio
-9.55
P/S (TTM)
6.18
P/B (TTM)
9.69
P/FCF
47.62
EV/EBITDA
-9674.27x
EV/Sales
—
ROE (TTM)
-1.32%
ROA (TTM)
-0.71%
ROIC
-0.01%
Gross Margin
0.80%
Operating Margin
-0.92%
Net Margin
-0.01%
Debt/Equity
0.02
Current Ratio
1.47
EPS Growth (YoY)
-6.35%
Revenue Growth (YoY)
+0.52%
EPS Growth (3Y)
-16.64%
EPS Growth (5Y)
-16.64%
Sales Growth (3Y)
+0.28%
Sales Growth (5Y)
+0.28%
EPS Est (This Year)
$1.91
EPS Est (Next Year)
$2.29
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.58
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $56.78(28.7% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
78.72M
Float
74.64M
Free Float %
94.82%
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
NYSE
IPO Date
2025-05-22
Employees
1514
CEO
Daniel A. Perez
Index Membership
—
Website
https://www.hingehealth.com
Hinge Health, Inc. (HNGE) is a healthcare company in the medical - healthcare information services industry listed on the NYSE. With a market capitalization of $3.47B, a P/E ratio of -5.58, HNGE is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HNGE against other stocks using dozens of fundamental and technical filters.
Hinge Health, Inc. (HNGE) has a trailing twelve-month (TTM) P/E ratio of -5.58. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Hinge Health, Inc. (HNGE) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Hinge Health, Inc. (HNGE) has a market capitalization of $3.47 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Hinge Health, Inc. (HNGE) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $56.78 implies 28.7% upside from the current price.